Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer [Phase 2]
Phase II study evaluating olaparib, a PARP inhibitor, with intravenous ascorbate for castration-resistant prostate cancer; the trial is term…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies [Phase 2]
Phase 2 clinical trial update reporting results from a study in prostate cancer evaluating maximal androgen depletion followed by randomizat…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Project HERO: Health Empowerment & Recovery Outcomes [NA]
Rutgers, The State University of New Jersey's Project HERO trial has completed, reporting health empowerment and recovery outcomes across m…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone [Phase 3]
Phase 3 study comparing hormonal therapy in combination with two dosing levels of radiation therapy to radiation therapy alone in prostate c…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer [Phase 2]
Phase 2 trial evaluating Cu-64-PSMA-I&T for PET imaging of metastatic PSMA-positive lesions in men with prostate cancer; results have been p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: PROVIZ - a Machine Learning Software, to Support Targeting of Prostate Biopsies on MR Images in Biopsy-naive Patients [NA]
Clinical trial update reporting the completion of a study evaluating PROVIZ, a machine learning software designed to guide targeting of pros…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Radiation-induced Diarrhoea During Curative EBRT of Prostate and Rectal Cancer
A completed clinical trial update evaluating radiation-induced diarrhoea during curative external beam radiotherapy for prostate and rectal …
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device [NA]
A completed validation trial evaluated removal of EpCAM-positive tumor cells from blood collected during tumor surgery using the Catumaxomab…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Fusion Versus Cognitive MRI Targeted Prostatic Biopsy [NA]
A completed clinical trial comparing fusion MRI-targeted biopsy with cognitive MRI-targeted biopsy for prostate cancer is reported. The exce…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer [Phase 1]
A Phase 1 trial evaluated oral BIBF 1120 (nintedanib) in combination with docetaxel and prednisone in patients with hormone-refractory prost…
-
CLINICAL_TRIALS trial_result · 2025-01-21Clinical Trial Update: STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer
A completed follow-up study evaluating men with prostate cancer on active surveillance as part of the STHLM3 AS NorDCaP trial.
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide [Phase 2]
This Phase 2 trial assesses pembrolizumab in patients with metastatic castration-resistant prostate cancer who were previously treated with …
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer [Phase 4]
Phase 4 study evaluating 18F-Fluciclovine PET-CT to measure therapeutic response in metastatic prostate cancer; the trial was terminated and…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer [NA]
A completed clinical trial evaluating stereotactic body radiation therapy for prostate cancer has posted results on 2025-01-16.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: 18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating 18F-PSMA-1007 PET imaging for detecting primary prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating metronomic oral vinorelbine in combination with anti-PD-L1 and anti-CTLA-4 immunotherapy for patients …
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening [NA]
Clinical trial update on community interventions in non-medical settings to improve informed decision making for prostate cancer screening. …
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning [Phase 2]
An update on a phase 2 trial evaluating neoadjuvant pembrolizumab in non-metastatic prostate cancer, using 18FDG-PET biomarker guidance.
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death
This is an update on a completed non-interventional study evaluating time to event and healthcare resource use in prostate cancer participan…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating a new method that uses confocal microscopy to detect residual tumours during prostate cancer…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci [NA]
This clinical trial update reports the completion of a study evaluating the Supersonic Imagine Aixplorer ultrasound technology for detecting…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer. [Phase 2]
A Phase 2 clinical trial evaluating the impact of 18F-PSMA PET/CT in managing prostate cancer has completed, assessing how this imaging stra…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: 68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated [NA]
A completed clinical trial evaluates Gallium-68 PSMA HBED-PET/CT imaging for evaluating biochemical relapse in men with a history of prostat…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Physical Function During ARSI Treatment
A completed clinical trial update evaluating physical function in patients with advanced prostate cancer treated with androgen receptor sign…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer [Phase 2]
Phase 2 trial evaluating Ibrutinib as neoadjuvant therapy for localized prostate cancer has completed, with results posted. The study was co…